Similar articles

• HPV testing in cervical screening.

  Cuzick J. Cuzick J. Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. doi: 10.1002/pds.558. Pharmacoepidemiol Drug Saf. 2001. PMID: 11417064 Review. No abstract available.
• HPV primary screening for cervical cancer: more pain than protection.

  Davey DD, Armenti CA. Davey DD, et al. Diagn Cytopathol. 2000 Jun;22(6):333-5. doi: 10.1002/(sici)1097-0339(200006)22:6<333::aid-dc1>3.0.co;2-8. Diagn Cytopathol. 2000. PMID: 10820524 No abstract available.
• Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

  Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J. Naucler P, et al. J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13. J Natl Cancer Inst. 2009. PMID: 19141778
• Human Papillomavirus DNA detection for cervical cancer screening.

  Press RD. Press RD. Mol Diagn. 2000 Sep;5(3):245-7. Mol Diagn. 2000. PMID: 11186127 No abstract available.
• [Current methods of diagnosis of uterine cervix precancer and cancer (a literature review)].

  Podistov IuI, Laktionov KP, Petrovichev NN. Podistov IuI, et al. Klin Lab Diagn. 2003 Mar;(3):15-24. Klin Lab Diagn. 2003. PMID: 12715392 Review. Russian. No abstract available.